top of page

Drug-Coated Balloon Might Be Major Advance for Refractory Strictures

Jun 23, 2021

GIE Publishing Team

A balloon coated with the anticancer agent paclitaxel appears to hold significant promise for the treatment of patients with complicated esophageal stents.

A balloon coated with the anticancer agent paclitaxel appears to hold significant promise for the treatment of patients with complicated esophageal stents.

One year after dilatation with the experimental therapy, from GIE Medical, eight of nine patients with benign strictures have yet to experience a recurrence, researchers have found. Although the data are preliminary, experts said the findings, reported at the 2021 Digestive Disease Week (abstract 818), could herald a major advance in the management of esophageal narrowing.

bottom of page